3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Head & Neck
2
Gastrointestinal
2
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Gynecologic
1
Genitourinary
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Stomach Neoplasms
2
Neuroendocrine Tumors
2
Esophageal Neoplasms
2
Colorectal Neoplasms
2
Cholangiocarcinoma
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Testicular Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pheochromocytoma
1
Pharyngeal Neoplasms
1
Penile Neoplasms
1
Parotid Neoplasms
1
Parathyroid Neoplasms
1
Pancreatic Neoplasms
1
Interventions
Paclitaxel
4
fosbretabulin
3
Radiotherapy
3
selpercatinib
2
Filgrastim
2
Everolimus
2
Doxorubicin
2
Cisplatin
2
vandetanib
1
tumor necrosis factor-alpha, CNGRC fusion protein, human
1
sargramostim
1
repotrectinib
1
pralsetinib
1
pentetreotide
1
pegfilgrastim
1
mercaptoundecahydrododecaborate
1
gallium Ga 68 dotatate
1
fostamatinib
1
entrectinib
1
combretastatin
1
alectinib
1
aldesleukin
1
Triiodothyronine
1
Thyrotropin Alfa
1
Thyrotropin
1
Thalidomide
1
Tamoxifen
1
Semaxinib
1
Rosiglitazone
1
Radiofrequency Ablation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Head and Neck Neoplasms
×
Quality of Life
×
Endocrine
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled